Published May 2021 | Version v1
Journal article

On the road to ending the COVID-19 pandemic: Are we there yet?

  • 1. Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110 (United States)
  • 2. Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110 (United States)
  • 3. The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, 63110 (United States)
  • 4. Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110 (United States)

Description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into the human population in late 2019 and caused the global COVID-19 pandemic. SARS-CoV-2 has spread to more than 215 countries and infected many millions of people. Despite the introduction of numerous governmental and public health measures to control disease spread, infections continue at an unabated pace, suggesting that effective vaccines and antiviral drugs will be required to curtail disease, end the pandemic, and restore societal norms. Here, we review the current developments in antibody and vaccine countermeasures to limit or prevent disease.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.virol.2021.02.003

Additional details

Identifiers

DOI
10.1016/j.virol.2021.02.003;
PII
S0042682221000374;

Publishing Information

Journal Title
Virology (New York, N.Y. Print)
Journal Volume
557
Journal Page Range
p. 70-85
ISSN
0042-6822
CODEN
VIRLAX

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54004235
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CORONAVIRUSES; IMMUNITY; PATHOGENESIS; PUBLIC HEALTH; REVIEWS; THERAPY; VACCINES
Descriptors DEC
DISEASES; DOCUMENT TYPES; INFECTIOUS DISEASES; MEDICINE; MICROORGANISMS; PARASITES; VIRAL DISEASES; VIRUSES; ZOONOTIC DISEASES

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.